DIAZOLE LACTAMS
    48.
    发明申请
    DIAZOLE LACTAMS 审中-公开

    公开(公告)号:US20160303084A1

    公开(公告)日:2016-10-20

    申请号:US15074976

    申请日:2016-03-18

    摘要: Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are diazole lactam derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated disease, and as controls in assays for the identification of competitive CCR1 antagonists.

    摘要翻译: 提供了作为CCR1受体的有效拮抗剂并具有体内抗炎活性的化合物。 这些化合物是二唑内酰胺衍生物,并且可用于药物组合物,用于治疗CCR1介导的疾病的方法,以及用于鉴定竞争性CCR1拮抗剂的测定中的对照。